{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:12:43Z","timestamp":1790539963084,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T00:00:00Z","timestamp":1423094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0003409","type":"journal-article","created":{"date-parts":[[2015,2,5]],"date-time":"2015-02-05T18:40:40Z","timestamp":1423161640000},"page":"e0003409","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Chemotherapy of Second Stage Human African Trypanosomiasis: Comparison between the Parenteral Diamidine DB829 and Its Oral Prodrug DB868 in Vervet Monkeys"],"prefix":"10.1371","volume":"9","author":[{"given":"John K.","family":"Thuita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina K.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Murilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene S.","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Boykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Mutuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan K.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles O.","family":"Gem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Tidwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Z.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary F.","family":"Paine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.biochi.2008.02.017","article-title":"Antiparasitic compounds that target DNA","volume":"90","author":"WD Wilson","year":"2008","journal-title":"Biochimie"},{"key":"ref2","unstructured":"WHO, 2011. Control of the Leishmanisis: Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22\u201326 March 2010. WHO Technical Report Series 949."},{"key":"ref3","unstructured":"World Health Organisation (2013) African Trypanosomiasis (sleeping sickness). <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/<\/ext-link>."},{"key":"ref4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1021\/jm00214a014","article-title":"Synthesis and antiprotozoal activity of 2,5-bis(4-guanylphenyl)furans","volume":"20","author":"BP Das","year":"1977","journal-title":"J. Med. Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0960-894X(96)00557-4","article-title":"Anti-pneumocystis activity of bis-amidoximes and bis-<italic>O<\/italic>alkylamidoximesprodrugs","volume":"6","author":"DW Boykin","year":"1996","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI200421052","article-title":"Human African trypanosomosis of the CNS: current issues and challenges","volume":"113","author":"PGE Kennedy","year":"2004","journal-title":"J. Clin. Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1021\/jm0302602","article-title":"Synthesis and anti-protozoal activity of aza-analogues offuramidine","volume":"46","author":"MA Ismail","year":"2003","journal-title":"J. Med. Chem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1023\/A:1020957430400","article-title":"Enhanced Permeability of the Antimicrobial Agent 2,5-Bis(4-Amidinophenyl)Furan across Caco-2 Cell Monolayers via Its MethylamidoximeProdrug","volume":"19","author":"L Zhou","year":"2002","journal-title":"Pharm Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1021\/jm030604o","article-title":"<italic>O<\/italic>-AlkoxyamidineProdrugs of Furamidine: In Vitro Transport and Microsomal Metabolism as Indicators of in Vivo Efficacy in a Mouse Model of <italic>Trypanosoma brucei rhodesiense<\/italic> Infection","volume":"47","author":"JH Ansede","year":"2004","journal-title":"J. Med. Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.actatropica.2008.07.006","article-title":"Efficacy of the diamidine DB75 and its prodrug DB289, against murine models of human African trypanosomiasis","volume":"108","author":"JK Thuita","year":"2008","journal-title":"Acta Trop Oct"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/AAC.00225-09","article-title":"New treatment option for second-stage African sleeping sickness: In vitro and in vivo efficacy of azaanalogs of DB289","volume":"53","author":"T Wenzler","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1128\/AAC.00831-08","article-title":"Efficacy of a novel diamidine compound 2, 5-bis (4-amidinophenyl)-furan-bis-O-methlylamidoxime (Pafuramidine, DB289) against <italic>T. b rhodesiense<\/italic> infection in vervet monkeys after oral administration","volume":"53","author":"RE Mdachi","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"ref13","doi-asserted-by":"crossref","first-page":"e1734","DOI":"10.1371\/journal.pntd.0001734","article-title":"Pharmacology of DB844, an Orally Active aza Analogue of Pafuramidine, in a MonkeyModel of Second Stage Human African Trypanosomiasis","volume":"6","author":"JK Thuita","year":"2012","journal-title":"PLoSNegl Trop Dis"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"e2230","DOI":"10.1371\/journal.pntd.0002230","article-title":"Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis","volume":"7","author":"JK Thuita","year":"2013","journal-title":"PLoSNegl Trop Dis"},{"key":"ref15","first-page":"795","article-title":"Animal models of CNS (second-stage) sleeping sickness","author":"C Gichuki","year":"1999"},{"key":"ref16","first-page":"e238","article-title":"<italic>Trypanosomabruceirhodesiense<\/italic> transmitted by a single tsetse fly bite in vervet monkeys as a model of Human African Trypanosomiasis","volume":"2","author":"JK Thuita","year":"2008","journal-title":"PloS NTD"},{"key":"ref17","first-page":"173","article-title":"Pre-clinical testing of potential trypanocidal drugs in primates: preliminary investigation of an experimental diamidine in vervets","author":"E Fink","year":"1980"},{"key":"ref18","first-page":"255","article-title":"<italic>T. b. rhodesiense<\/italic> infection in vervet monkeys. II. Provocation of the encephalitic late phase by treatment of infected monkeys","volume":"33","author":"H Schmidt","year":"1982","journal-title":"Tropenmed. Parasitol"},{"key":"ref19","first-page":"249","article-title":"<italic>T. b. rhodesiense<\/italic> infection in vervet monkeys. I. Parasitologic, hematologic, immunologic and histologic results","volume":"33","author":"H Schmidt","year":"1982","journal-title":"Tropenmed. Parasitol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF00612951","article-title":"The pathogenesis of trypanosomiasis of the CNS: studies on parasitological and neurohistological findings in <italic>Trypanosoma rhodesiense<\/italic> infected vervet monkeys","volume":"399","author":"H Schmidt","year":"1983","journal-title":"Virchows Arch [PatholAnat]"},{"key":"ref21","first-page":"183","article-title":"IgG and IgM levels in serum and CSF of <italic>T. rhodesiense<\/italic>-infected vervet monkeys","volume":"7","author":"E Fink","year":"1983","journal-title":"ContribMicrobiolImmunol"},{"key":"ref22","first-page":"124","article-title":"Total protein and white cell changes in the cerebrospinal fluid of vervet monkeys infected with <italic>Trypanosomarhodesiense<\/italic> and post-treatment reaction","volume":"4","author":"JM Ndung\u2019u","year":"1994","journal-title":"J Protozool Res"},{"key":"ref23","first-page":"10","article-title":"Use of TrypTectCIAAT to determine the effectiveness of treatment of <italic>Trypanosomabruceirhodesiense<\/italic> infections in vervet monkeys (Chlorocebusaethiops) and man","volume":"20","author":"SM Karanja","year":"2010","journal-title":"J Protozool Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0014-4894(76)90110-7","article-title":"<italic>Trypanosomabrucei<\/italic>: a rapid \u2018matching\u2019 method for estimating the host\u2019s parasitaemia","volume":"40","author":"WJ Herbert","year":"1976","journal-title":"Exp. Parasitol"},{"key":"ref25","first-page":"384","article-title":"The haematocrit centrifuge technique for the diagnosis ofAfrican trypanosomiasis","volume":"27","author":"PT Woo","year":"1970","journal-title":"Acta Trop"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0035-9203(00)90327-4","article-title":"Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid, and sensitive detection of trypanosomes","volume":"94","author":"TW Miezan","year":"2000","journal-title":"Trans. R. Soc. Trop. Med. Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1128\/AAC.01551-10","article-title":"Trypanocidal furamidine analogues: influence of pyridine nitrogens on trypanocidal activity, transport kinetics, and resistance patterns","volume":"55","author":"CP Ward","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","unstructured":"Wolf KK, DeSmet K, Bridges A, Tidwell R, Paine MF, et al. (2012) Two structurally similar anti-parasitic prodrugs differ markedly in toxicity profiles (Abstract ID#2928). Society of Toxicology Annual Meeting Abstract Supplement (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/wwwtoxicologyorg\/AI\/Pub\/Tox\/2012ToxSuppdf\" xlink:type=\"simple\">http:\/\/wwwtoxicologyorg\/AI\/Pub\/Tox\/2012ToxSuppdf<\/ext-link>)."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/00498250500087671","article-title":"In vitro metabolism of an orally active O-methyl amidoximeprodrug for the treatment of CNS trypanosomiasis","volume":"35","author":"JH Ansede","year":"2005","journal-title":"Xenobiotica"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/AAC.00192-06","article-title":"Accumulation and intracellular distribution of antitrypanosomaldiamidine compounds DB75 and DB820 in African trypanosomes","volume":"50","author":"AM. Mathis","year":"2006","journal-title":"Antimicrob. Agents Chemother"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0001-706X(94)90120-1","article-title":"Pharmacokinetics of melarsoprol in uninfected vervet monkeys","volume":"58","author":"C Burri","year":"1994","journal-title":"Acta Trop"},{"key":"ref32","first-page":"1136","article-title":"The blood-brain barrier significantly limits eflornithine entry into <italic>Trypanosomabruceibrucei<\/italic> infected mouse brain","volume":"107","author":"L Sanderson","year":"2008","journal-title":"JNC"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.trstmh.2005.07.023","article-title":"The vervet monkey (Chlorocebusaethiops) as an experimental model for <italic>Trypanosomabruceigambiense<\/italic> human African trypanosomiasis: a clinical, biological and pathological study","volume":"100","author":"O Ouwe-Missi-Oukem-Boyer","year":"2006","journal-title":"Trans R Trop Med Hyg"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2217\/fmb.11.44","article-title":"Development of novel drugs for human African trypanosomiasis","volume":"6","author":"R Brun","year":"2011","journal-title":"Future Microbiol"},{"key":"ref35","article-title":"Towards Point-of-Care Diagnostic and Staging Tools for Human African Trypanosomiaisis","author":"E Matovu","year":"2012","journal-title":"J Trop Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1098\/rspb.2001.1794","article-title":"Limitation of <italic>Trypanosomabrucei<\/italic>parasitaemia results from density-dependent parasite differentiation and parasite killing by the host immune response Proc","volume":"268","author":"KM Tyler","year":"2001","journal-title":"R. Soc. Lond"},{"issue":"1","key":"ref37","first-page":"14","article-title":"Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with <italic>Trypanosomabruceirhodesiense<\/italic>","volume":"119","author":"M Ngotho","year":"2011","journal-title":"Acta Trop. 2011 Jul"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"e1662","DOI":"10.1371\/journal.pntd.0001662","article-title":"Early Prediction of Treatment Efficacy in Second-Stage Gambiense Human AfricanTrypanosomiasis","volume":"6","author":"G Priotto","year":"2012","journal-title":"PLoSNegl Trop Dis"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"e1246","DOI":"10.1371\/journal.pntd.0001246","article-title":"Prevalence of Human African Trypanosomiasis in the Democratic Republic of theCongo","volume":"5","author":"D Mumba","year":"2011","journal-title":"PLoSNegl Trop Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1371\/journal.pmed.0050055","article-title":"Eliminating human African trypanosomiasis: where do we stand and what comes next","volume":"5","author":"P.P. Simarro","year":"2008","journal-title":"PLoS Med"},{"key":"ref41","article-title":"Towards Point-of-Care diagnostic and staging tools for human African trypanosomiaisis","author":"E Matovu","year":"2012","journal-title":"J Trop Med"},{"issue":"10","key":"ref42","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1128\/AAC.00225-09","article-title":"New treatment option for second-stage African sleeping sickness: In vitro and in vivo efficacy of azaanalogs of DB289","volume":"53","author":"T Wenzler","year":"2009","journal-title":"Antimicrob agents and chemother"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1128\/AAC.00398-13","article-title":"Pharmacokinetics, <italic>Trypanosomabruceigambiense<\/italic> efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis","volume":"57","author":"T. Wenzler","year":"2013","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0003409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T17:29:28Z","timestamp":1566322168000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0003409"}},"subtitle":[],"editor":[{"given":"Philippe","family":"B\u00fcscher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,2,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0003409","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}